- Report
- May 2023
- 169 Pages
Global
From €1818EUR$1,880USD£1,561GBP
€2272EUR$2,350USD£1,951GBP
- Report
- November 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- December 2023
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- March 2024
- 91 Pages
North America
From €1450EUR$1,500USD£1,246GBP
- Report
- April 2021
- 47 Pages
Global
€21269EUR$22,000USD£18,269GBP
- Report
- January 2019
- 717 Pages
Global
From €21269EUR$22,000USD£18,269GBP
- Report
- April 2022
- 34 Pages
Global
From €1885EUR$1,950USD£1,619GBP
From €7251EUR$7,500USD£6,228GBP
- Report
- October 2018
- 68 Pages
Global
From €6187EUR$6,400USD£5,315GBP
- Report
- August 2023
- 117 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Book
- November 2022
- 176 Pages
- Book
- September 2022
- 352 Pages
- Book
- April 2021
- 432 Pages
- Book
- April 2019
- 176 Pages
- Book
- January 2017
- 576 Pages
- Book
- January 2014
- 384 Pages
- Book
- September 2013
- 352 Pages
- Book
- April 2010
- 754 Pages
- Book
- July 2018
- 200 Pages
United States
The Immunodeficiency market is a subset of the Allergy and Immunology field, which focuses on the diagnosis and treatment of immune system disorders. Immunodeficiency is a condition in which the body's immune system is weakened or unable to function properly, making it more susceptible to infections and other diseases. Common immunodeficiency disorders include primary immunodeficiency diseases, secondary immunodeficiency diseases, and acquired immunodeficiency syndrome (AIDS). Treatment for immunodeficiency disorders typically involves medications, such as immunoglobulins, to boost the body's immune system, as well as lifestyle changes to reduce the risk of infection.
Companies in the Immunodeficiency market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. These companies specialize in the development and manufacture of immunoglobulins, as well as other treatments for immunodeficiency disorders. Show Less Read more